Published in Liver Int on May 19, 2008
The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites. Aliment Pharmacol Ther (2010) 1.49
Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (2012) 1.30
Kidneys in chronic liver diseases. World J Gastroenterol (2012) 1.10
Clinical use of albumin in hepatology. Blood Transfus (2009) 0.96
Hepatorenal syndrome. World J Gastroenterol (2012) 0.93
Evaluation and management of patients with refractory ascites. World J Gastroenterol (2009) 0.89
Beneficial effect of midodrine in hypotensive cirrhotic patients with refractory ascites. Gastroenterol Hepatol (N Y) (2011) 0.75
What is the Role of Midodrine in Patients with Decompensated Cirrhosis? Gastroenterol Hepatol (N Y) (2011) 0.75
Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis. BMC Gastroenterol (2015) 0.75
The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis. Clin Gastroenterol Hepatol (2012) 0.75
Role of albumin in cirrhosis: from a hospitalist's perspective. J Community Hosp Intern Med Perspect (2017) 0.75
A meta-analysis of the association between adherence to drug therapy and mortality. BMJ (2006) 7.79
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care (2005) 4.78
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet (2013) 4.58
Self-denigration in pharmacy: Words to banish from the pharmacy lexicon / Autodénigrement en pharmacie : mots à bannir du vocabulaire des pharmaciens. Can Pharm J (Ott) (2014) 4.19
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ (2007) 3.95
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med (2009) 3.70
Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol (2011) 3.64
A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med (2008) 3.21
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol (2006) 3.20
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Guidelines for pharmacists integrating into primary care teams. Can Pharm J (Ott) (2013) 3.05
Effect of fish oil on arrhythmias and mortality: systematic review. BMJ (2008) 2.76
Angiotensin receptor blockers and risk of myocardial infarction: systematic review. BMJ (2005) 2.57
Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676]. Med Care (2009) 2.56
Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ (2004) 2.55
Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med (2008) 2.55
Self-denigration in pharmacy: Actions that should be curtailed. Can Pharm J (Ott) (2014) 2.51
Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review. Ann Intern Med (2012) 2.35
Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl (2012) 2.26
Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother (2005) 2.22
Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting. J Interprof Care (2009) 2.19
Validity and reliability of the Edmonton Frail Scale. Age Ageing (2006) 2.08
Stories from the trenches: Experiences of Alberta pharmacists in obtaining additional prescribing authority. Can Pharm J (Ott) (2012) 2.04
Pharmacists' self-perception of their professional role: insights into community pharmacy culture. J Am Pharm Assoc (2003) (2011) 1.89
The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis. Nephrol Dial Transplant (2009) 1.89
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83
Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study. CMAJ (2006) 1.80
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl (2004) 1.80
Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007. Liver Int (2008) 1.77
Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes (2013) 1.75
Enhancing primary care for complex patients. Demonstration project using multidisciplinary teams. Can Fam Physician (2004) 1.74
Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial. Am Heart J (2007) 1.73
Pharmacists' perceptions of their professional role: insights into hospital pharmacy culture. Can J Hosp Pharm (2011) 1.72
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol (2007) 1.70
Long-term association between frailty and health-related quality of life among survivors of critical illness: a prospective multicenter cohort study. Crit Care Med (2015) 1.62
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet (2010) 1.62
The Enhancing Secondary Prevention in Coronary Artery Disease trial. CMAJ (2009) 1.57
Risk factors for recurrence of autoimmune hepatitis after liver transplantation. Liver Transpl (2009) 1.55
Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome. Hepatology (2002) 1.50
Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial. Clin Gastroenterol Hepatol (2008) 1.50
Relation of T-axis abnormalities to coronary artery disease and survival after cardiac catheterization. Am J Cardiol (2005) 1.48
Exploring the treatment-risk paradox in coronary disease. Arch Intern Med (2007) 1.48
Urgent clinical challenges in children with ischemic stroke: analysis of 1065 patients from the 1-800-NOCLOTS pediatric stroke telephone consultation service. Stroke (2005) 1.47
Stroke prophylaxis in institutionalized elderly patients with atrial fibrillation. J Am Geriatr Soc (2004) 1.47
Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open (2013) 1.45
A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy (2012) 1.42
Ontario pharmacists' crisis over Bill 16: A missed opportunity? Can Pharm J (Ott) (2012) 1.40
The misrepresentation of high drug costs: Who is looking out for the patient? Can Pharm J (Ott) (2017) 1.39
Duplication of MER115 on chromosome 4 in patients with primary biliary cirrhosis. Liver Int (2008) 1.39
On becoming a new pharmacist. Can Pharm J (Ott) (2013) 1.38
Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3. Gastroenterology (2010) 1.38
Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study. CMAJ (2013) 1.35
Significant association with location of central venous line placement and risk of venous thrombosis in children. Thromb Haemost (2005) 1.32
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet (2012) 1.32
Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood (2003) 1.31
Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care (2010) 1.31
Personality traits of hospital pharmacists: toward a better understanding of factors influencing pharmacy practice change. Can J Hosp Pharm (2013) 1.27
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines. Can J Gastroenterol (2012) 1.27
The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation. Can J Cardiol (2003) 1.25
The genetics of complex cholestatic disorders. Gastroenterology (2013) 1.24
Hypertension in people with type 2 diabetes: Update on pharmacologic management. Can Fam Physician (2011) 1.17
Patient and informal caregivers' knowledge of heart failure: necessary but insufficient for effective self-care. Eur J Heart Fail (2009) 1.16
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol (2008) 1.15
Chemical contamination in southwest Puerto Rico: an assessment of organic contaminants in nearshore sediments. Mar Pollut Bull (2008) 1.14
Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care. Open Med (2009) 1.12
Pharmacists' duty of care / Obligation de diligence du pharmacien. Can Pharm J (Ott) (2013) 1.12
De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation (2007) 1.11
Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods. Implement Sci (2011) 1.11
Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. J Control Release (2005) 1.10
Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol (2013) 1.10
Mouse retroviruses and chronic fatigue syndrome: Does X (or P) mark the spot? Proc Natl Acad Sci U S A (2010) 1.09
Reaffirming our focus on patient-centred care. Can Pharm J (Ott) (2015) 1.08
Publicly funded remuneration for the administration of injections by pharmacists: An international review. Can Pharm J (Ott) (2013) 1.08
A cross-sectional study evaluating post-thrombotic syndrome in children. Thromb Res (2003) 1.06
Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thromb Haemost (2002) 1.06
Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality. Trials (2009) 1.05
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol (2009) 1.04
Developmental hemostasis: pro- and anticoagulant systems during childhood. Semin Thromb Hemost (2003) 1.03
Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service. Thromb Haemost (2004) 1.02
Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review. Pediatrics (2010) 1.02
The expanding scope of pharmacists' practice: implications for physicians. CMAJ (2013) 1.01
Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients. Circ Heart Fail (2013) 1.01
Elevated lipogenesis and diminished cholesterol synthesis in patients with hepatitis C viral infection compared to healthy humans. Hepatology (2013) 1.01
Effect of a prior authorization process on antiplatelet therapy and outcomes in patients prescribed clopidogrel following coronary stenting. Can J Cardiol (2006) 1.01
Multidisciplinary approaches to the management of high blood pressure. Curr Opin Cardiol (2014) 1.00
Prediction of cardiac complications after liver transplantation. Transplantation (2009) 1.00
Characterization of organic chemical contaminants in sediments from Jobos Bay, Puerto Rico. Environ Monit Assess (2011) 0.99
Results of a national survey on over-the-counter medicines, Part 1: Pharmacist opinion on current scheduling status. Can Pharm J (Ott) (2012) 0.99
Pharmacy 2.0: a scoping review of social media use in pharmacy. Res Social Adm Pharm (2013) 0.98
A case series of 72 neonates with renal vein thrombosis. Data from the 1-800-NO-CLOTS Registry. Thromb Haemost (2004) 0.98